Hologic (HOLX) Tops Q2 EPS by 1c; Lifts Outlook
Get Alerts HOLX Hot Sheet
Price: $76.71 --0%
Revenue Growth %: -2.5%
Financial Fact:
Amortization of intangible assets: 22.4M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: -2.5%
Financial Fact:
Amortization of intangible assets: 22.4M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Hologic (NASDAQ: HOLX) reported Q2 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $818.4 million versus the consensus estimate of $806.5 million.
GUIDANCE:
Hologic sees Q3 2019 EPS of $0.60-$0.62, versus the consensus of $0.62. Hologic sees Q3 2019 revenue of $825-840 million, versus the consensus of $840.02 million.
Hologic sees FY2019 EPS of $2.41-$2.44, versus the consensus of $2.41. Hologic sees FY2019 revenue of $3.325-3.345 billion, versus the consensus of $3.32 billion.
For earnings history and earnings-related data on Hologic (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- STMicroelectronics cuts outlook as slower demand causes Q1 miss
- Uxin Limited (UXIN) Tops Q3 EPS by 49c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!